Trials / Completed
CompletedNCT04205396
CAREGIVER: A Trial to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis
CAREGIVER: An Randomized Clinical Trial (RCT) to Improve the Burden and Distress of Caring for Persons With Decompensated Cirrhosis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 87 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this study is to enroll caretakers of patients with decompensated cirrhosis to determine if written emotional disclosure or resilience training interventions reduce distress and burden among primary informal caregivers. Caretakers that meet eligibility will complete baseline assessments in person, or if necessary, over the phone and be randomized to be in one of three arms of this study. Materials specific to each study arm will be mailed to the caretakers home along with instructions. Overall, the study will take approximately 2 months and a qualitative interview will also be completed around 3-6 months post-baseline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Written emotional disclosure | Participants will write five stories (days 8, 11, 14, 17 and 20) about an assigned topic relating to their experiences as a caregiver of someone with advanced liver disease. Rules for the exercise will be provided in an instructions page. Additionally, baseline and outcome measures will be completed. |
| BEHAVIORAL | Resilience training | Participants will write three things that went well at the end of their day (before going to sleep), and what was their role in bringing them. These will be done about every three days (days 8, 11, 14, 17 and 20) for 2 weeks at home. Rules for the exercise will be provided in an instructions page. Additionally, baseline and outcome measures will be completed. |
| OTHER | No treatment | Participants will complete baseline and outcome assessments and no intervention will be conducted. |
Timeline
- Start date
- 2020-02-10
- Primary completion
- 2022-03-22
- Completion
- 2022-03-22
- First posted
- 2019-12-19
- Last updated
- 2022-04-15
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04205396. Inclusion in this directory is not an endorsement.